首页> 外文期刊>Biotechnology and Applied Biochemistry >Conjugation to octa-arginine via disulfide bonds confers solubility to denatured proteins in physiological solution and enables efficient cell internalization
【24h】

Conjugation to octa-arginine via disulfide bonds confers solubility to denatured proteins in physiological solution and enables efficient cell internalization

机译:通过二硫键与八-精氨酸的缀合赋予生理溶液中变性蛋白质的溶解度,并使细胞有效内化

获取原文
获取原文并翻译 | 示例
       

摘要

Some protein transduction methods have already been developed for regenerative medicine application. These methods can be applied to soluble proteins but not to insoluble proteins, such as those that originate from inclusion bodies, for example, Escherichia coli. We have developed a method that allows the in vitro solubilization of denatured proteins without refolding and their efficient cellular internalization through conjugation to the peptide, octa-arginine (R8), via disulfide bonds with cysteine residues. Ovalbumin (OVA), denatured in urea solution containing dithiothreitol, was used as a model protein. The R8 peptide was conjugated with OVA in urea solution. Denatured OVA was recovered in the insoluble fraction after dialysis against phosphate-buffered saline. However, almost all the R8-conjugated OVA was recovered in the soluble fraction and used for translocation experiments in HeLa, Chinese hamster ovary-K1, Cos-7, and matured dendritic cells, where efficient internalization of the protein conjugate was observed. Furthermore, we formulated R8-conjugated β-galactosidase and R8-conjugated luciferase using a similar procedure, and investigated how the conjugated proteins are processed after cell internalization. We also observed that only a small fraction of these proteins refolded and almost all underwent intracellular degradation. These results suggest that this method is suitable for the transduction of antigen-presenting cells and will benefit research and innovation in vaccine design and discovery.
机译:已经开发出一些蛋白质转导方法用于再生医学。这些方法可以应用于可溶性蛋白质,但不能应用于不溶性蛋白质,例如源自包涵体的蛋白质,例如大肠杆菌。我们已经开发出一种方法,该方法可以使变性蛋白质在体外溶解而无需重新折叠,并且可以通过与半胱氨酸残基的二硫键与肽八-精氨酸(R8)偶联来有效地细胞内在化。在含有二硫苏糖醇的尿素溶液中变性的卵清蛋白(OVA)被用作模型蛋白。将R8肽与尿素溶液中的OVA缀合。用磷酸盐缓冲液透析后,在不溶级分中回收了变性的OVA。但是,几乎所有R8缀合的OVA均在可溶性级分中回收,并用于HeLa,中国仓鼠卵巢K1,Cos-7和成熟的树突状细胞的易位实验,其中观察到了蛋白缀合物的有效内在化。此外,我们使用相似的步骤配制了R8缀合的β-半乳糖苷酶和R8缀合的荧光素酶,并研究了细胞内化后如何处理缀合的蛋白质。我们还观察到这些蛋白质中只有一小部分会重新折叠,几乎所有的蛋白质都会发生细胞内降解。这些结果表明该方法适用于抗原呈递细胞的转导,并且将有益于疫苗设计和发现的研究和创新。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号